Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q4 2025 | 135.47% |
| Q3 2025 | -2207.94% |
| Q2 2025 | 85.06% |
| Q1 2025 | 14.48% |
| Q4 2024 | -159.15% |
| Q3 2024 | 169.03% |
| Q2 2024 | 123.87% |
| Q1 2024 | 212.92% |
| Q4 2023 | 195.87% |
| Q3 2023 | -147.43% |
| Q2 2023 | 620.38% |
| Q1 2023 | -111.07% |
| Q4 2022 | 220.37% |
| Q3 2022 | 64.16% |
| Q2 2022 | -162.96% |
| Q1 2022 | -200.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -2.00% |
| Q4 2020 | 195.94% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |